Abionyx Pharma SA (ABNX) — Cash Flow Quality Index
Latest as of June 2019:
-1.02x
Abionyx Pharma SA (ABNX) has a Cash Flow Quality Index of -1.02x as of June 2019. Operating cash flow of €-2.96 Million is below net income of €2.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Abionyx Pharma SA (ABNX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-1.02x
Operating CF / Net Income
Operating Cash Flow
€-2.96 Million
EUR
Net Income
€2.90 Million
EUR
Data as of
Jun 2019
Most recent filing
Abionyx Pharma SA Cash Flow Quality Index (2019–2019)
Historical Cash Flow Quality Index for Abionyx Pharma SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ABNX cash flow metrics.
Annual Cash Flow Quality Index for Abionyx Pharma SA (2019–2019)
Year-by-year earnings quality comparison for Abionyx Pharma SA.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -2.14x | €-3.95 Million | €1.85 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.